New strategies to improve the efficacy of CAR T-cell therapy in solid tumours

by Fundació Clínic per a la Recerca Biomèdica

More specifically, it demonstrates how the affinity of the CAR T-cell to the tumour receptor modulates both its efficacy and resistance to the suppressive mechanisms of solid tumours.

Read more

Persistent symptoms after treatment in a type of autoimmune encephalitis are characterized

by Fundació Clínic per a la Recerca Biomèdica

A study coordinated by the Clínic-IDIBAPS and published in The Lancet Neurology, has examined the symptoms experienced by patients with anti-LGI1 encephalitis—a type of autoimmune encephalitis—af...

Read more

A study by BCNatal and UPF opens the door to designing therapies to improve lung development in growth-restricted fetuses

by Fundació Clínic per a la Recerca Biomèdica

It has been provided new scientific evidence that shows that problems with lung development in a fetus that grows below normal levels are related to vascular resistance.

Read more

Una beca europea permitirá avanzar en el diagnóstico y tratamiento de las Enfermedades Vasculares Portosinusoidales

by Fundació Clínic per a la Recerca Biomèdica

El proyecto RiTA (Enfermedades Vasculares PortoSinusoidales: Estratificación de Riesgos y Enfoques Terapéuticos, por sus siglas en inglés), que ha empezado en abril 2024, tiene como objetivo princi...

Read more

The amino acid L-serine shows efficacy in treating patients with mutations in GRIN genes

by Fundació Clínic per a la Recerca Biomèdica

A clinical trial has demonstrated the potential of the amino acid L-serine, administered as an oral supplement, to improve the function of glutamate receptors in patients with GRINpathies.

Read more

Doctors from the Hospital Clínic-IDIBAPS authors of an article proposing possible population screening strategies for liver fibrosis

by Fundació Clínic per a la Recerca Biomèdica

A team of experts from the European consortium LIVERSCREEN, led by IDIBAPS and funded through the Horizon 2020 programme, used their expertise and all they learnt in the colorectal and lung cancer scr...

Read more

Changes in the immune system response play a key role in the progression of pulmonary fibrosis

by Fundació Clínic per a la Recerca Biomèdica

Researchers at the Hospital Clínic-IDIBAPS have assessed the role of the immune system in patients with idiopathic pulmonary fibrosis (IPF) through three studies.

Read more

El Clínic, primer hospital de España en extirpar tumores del oído medio a través de cirugía endoscópica

by Fundació Clínic per a la Recerca Biomèdica

Un estudio demuestra que esta técnica mínimamente invasiva es segura y eficaz en la fase inicial de tumores del oído medio, y que disminuye el tiempo de hospitalización de los pacientes.

Read more

A European project led by IDIBAPS wants to advance precise spatiotemporal control of brain activity for therapeutic purposes

by Fundació Clínic per a la Recerca Biomèdica

Funded by the European Union, META-BRAIN project presents an innovative approach to controlling brain activity by means of nanotechnology, with reduced magnetic field requirements, wireless capability...

Read more

The Hospital Clínic-IDIBAPS leads the largest European study to date on liver disease

by Fundació Clínic per a la Recerca Biomèdica

The project, funded by the European Union and endowed with a budget of 24.8 million euros, aims to identify a large set of biomarkers that allow liver disease to be detected in the earliest stages, an...

Read more

Hospital Clínic-IDIBAPS researchers review adjuvant treatment with immunotherapy and vaccines for liver cancer

by Fundació Clínic per a la Recerca Biomèdica

The combination of surgery with adjuvant immunotherapy, after surgery, was shown to improve disease-free survival rates in the last IMbrave 050 phase III study

Read more

A European study in people with the participation of Clínic-IDIBAPS shows that treatment with the drug Abatacept reduces the risk of developing rheumatoid arthritis

by Fundació Clínic per a la Recerca Biomèdica

Published in the journal The Lancet, the study presents the results of Abatacept, a drug that modulates the activation of T cells, which play a key role in the progression of the disease.

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

ORYZON selected as Associated Partner in...

by Oryzon Genomics

Oryzon to validate epigenetic agents by applying a personalized medici...

Photos Stream